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Background: Neuromuscular electric stimulation is widely used for muscle
strengthening in clinical practice and for preventative purposes. However, there are
few reports on the effects of electric stimulation on the immune response of the
organism, and even those mainly describe the changes observed immediately after
the electrotherapeutic procedures. The objective of our study was to examine the
possible immunological consequences of moderate low-frequency transcutaneous
neuromuscular electric stimulation for quadriceps muscle strengthening in healthy
individuals.
Methods: The study included 10 healthy volunteers (5 males, 5 females, mean age
37.5 years). At the beginning and after a two-week electric stimulation program,
muscle strength was measured and peripheral blood was collected to analyse white
blood cells by flow cytometry for the expression of cell surface antigens (CD3, CD19,
CD4, CD8, CD4/8, DR/3, NK, Th reg, CD25 + CD3+, CD25 + CD4+, CD25 + CD8+,
CD69 + CD3+, CD69 + CD4+, CD69 + CD8+) and phagocytosis/oxidative killing
function.
Results: Muscle strength slightly increased after the program on the dominant and
the nondominant side. No statistically or clinically significant difference was found in
any of the measured blood and immune cells parameters as well as phagocytosis
and oxidative burst function of neutrophil granulocytes and monocytes one day
after the program.
Conclusions: The program of transcutaneous low-frequency electric stimulation
slightly strengthened the quadriceps femoris muscle while producing no changes in
measured immunological parameters. Hence, therapeutic low-frequency electric
stimulation appears not to be affecting the immune response of healthy persons.
Keywords: Electric stimulation, Quadriceps femoris muscle, Immune response,
Healthy volunteersBackground
The use of low-frequency electric stimulation for therapeutic purposes has been in-
creasing during the last decades [1]. In physiatric clinical practice, peripheral electric
stimulation is mostly used as neuromuscular electric stimulation (NMES) to improve
muscle performance [2,3], but also for pain management [4,5], for healing process en-
hancement in bone and chronic wounds [6,7], and for increasing blood circulation© 2012 Kopitar et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
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arrhythmias, cardiac pacemakers, pregnancy in women, malignant tumours and many
other [10,11]. At the same time, numerous physiological effects of electric stimulation
have been noted [12,13], as well as psychological ones [14,15].
In recent years, much effort is being invested in clarifying possible health risk of ex-
tremely low frequency (ELF) electromagnetic fields from the environment and from dif-
ferent man-made sources. There are increasing concerns of possible effects of different
sources of electromagnetic fields on human health, one of them being high-voltage
power lines [16]. At the same time, many medical diagnostic and therapeutic applica-
tions of ELF fields operate in the same frequency range, but of course with quite differ-
ent electric field strength [17]. There is also evidence on the connection between
certain electrotherapeutic regimes and the nervous-endocrine-immune interactions
[18], whereby proper functioning of the immune system is essential for good health.
Our study deals with NMES and its possible effects upon the immune status of the
stimulated person. NMES has been used as a complementary tool to therapeutic exer-
cise for muscle strengthening either in clinical practice or for preventative purposes for
many years. However, NMES alone yields no higher benefits than traditional strength-
ening methods [19]. Given the widespread use of NMES, there are surprisingly few
reports on the effects of such electric stimulation on the immune response of the or-
ganism. The existing reports, which are listed and considered in detail in the discus-
sion, describe either the changes in white blood cells observed immediately after the
electrotherapeutic procedures or in a few hours afterwards, or changes in circulating
neuroendocrine and inflammatory mediators after some weeks of electric stimulation.
We could not find any studies addressing eventual changes in phagocytosis and/or oxi-
dative killing function in the days following the completion of a NMES program on
healthy persons, which is why we performed such a study.
Methods
Participants
The participants of the study were randomly selected healthy working adults, five
women and five men, aged between 25 and 67 years (mean 37.5 years, SD 12.6 years).
They had had no electrotherapy for six months prior to inclusion in the study. Upon
inclusion in the study, the participants self-assessed the grade of their physical activity
(PA) during the last 4 weeks on a 7-point scale (1 = none or little; 2 = light or moderate
PA, but not every week; 3 = light PA every week; 4 =moderate PA for less than 30 min
every week or light PA 5 times/week; 5 = heavy PA for less than 20 min every week or
moderate PA 3 times/week; 6 =moderate PA for at least 30 min at least 5 times/week;
7 = heavy PA for at least 20 min a least 3 times/week). The grade ranged from 3 to 7,
with a mean of 5.4. The participants did not change their habits regarding PA during
the study – their self-ratings were the same at the end of the study.
All participants signed an informed consent statement. The study was approved by
the institutional Research Ethics Committee.
Neuromuscular electric stimulation
Knee extensor muscles (m. quadriceps femoris) were electrically stimulated on both
legs for 10 consecutive working days. The participant selection criteria ensured that all
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safety measures [20] were undertaken. A two-channel electric stimulator (FEDA PO 32,
Soca oprema, Ljubljana, Slovenia) with a voltage outlet was used. The stimulator pro-
duces monophasic rectangular pulses of 0.3 ms width and frequency of 20 Hz. The in-
tensity of electric stimulation was set to remain under the pain threshold and ranged
from 30 to 50 V (PP) or from 6 to 8 V (RMS), respectively. This was sufficient to elicit
light isotonic contraction of the stimulated musculature. The pair of electrodes (self-
adhesive rectangular surface electrodes of size 4.5 × 9.0 cm, Valutrode Lite, Neuro-
stimulation Electrodes, Model VL4595, Axelgaard Manufactoring, USA) were fixed
to the frontal part of the thigh, with one electrode placed between the upper and
the middle third of the thigh and the other electrode placed between the middle
and the lower third of the thigh. The electric stimulation was cyclic (7 s of stimula-
tion alternated with 7 s of pause, reciprocally with respect to the dominant/nondo-
minant leg), lasting for 20 min daily. The participants were stimulated in lying
position on the back with slightly flexed knees (an angle of about 30°).
Each participant underwent bilateral knee extensor muscle strengthening training
using NMES for 10 consecutive working days within a two-week period. On the day be-
fore the start of the training program and after the training, knee extensor muscle
strength was measured as maximum torque of isometric contraction during voluntary
extension of the knees. Before the start of the NMES training (in the morning of the
day of the first session) and one day after the end of the training peripheral blood sam-
ples were taken for determining biochemical and immune response markers.
Dynamometric measurements of muscle strength
The measurements of muscle strength (in Nm) were performed on a Biodex System 2
dynamometer. The participants were seated with knees fixed in the flexion position
(60°). Maximum voluntary isometric contraction (MVIC) was measured for 5 s with 3
repetitions separated by 20 s breaks. The measurements were performed first on the
dominant and then on the nondominant side. The mean MVIC of knee extensor mus-
cles from the 3 repetitions was used for analysis.
Blood tests
The blood samples were obtained from the cubital vein taken prior to starting of the
treatment with electric stimulation (on the same day of the first session in the morning)
and after completion of the treatment (in the morning after the last session). The BD
Diagnostics Vacutainer Plastic tubes were used to get samples of serum, plasma or
whole blood for the laboratory analyses.
The following blood tests were performed:
 Biochemical determination of sodium, potassium, calcium, chlorine, glucose, urea,
creatinine, creatine kinase, cortisol and C-reactive protein (CRP);
 Differential white blood cell count (leucocytes, lymphocytes, neutrophils,
monocytes);
 Determination of lymphocytes with following characteristics: CD3, CD19, CD4,
CD8, CD4/CD8, HLA-DR/CD3, CD56, CD25++CD4+ (Th reg), CD25 +CD3+,
CD25+CD4+, CD25+CD8+, CD69 +CD3+, CD69 +CD4+, CD69 +CD8+;
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phagocytosis test of monocytes with FITC labelled E. coli (FTm);
 Oxidative burst test of E. coli stimulated neutrophil granulocytes with
dihydrorhodamine 123 (Ecg);
 Oxidative burst test of E. coli stimulated monocytes with dihydrorhodamine 123
(Ecm).Acquisition of immunologic data
Determination of potential activation changes in three white blood cell groups- lym-
phocytes, neutrophil granulocytes and monocytes - was performed. Lymphocytes were
analysed for the expression of cell surface antigens using the following combination of
antibodies HLA-DR-FIRC/CD3-PE, CD25-FITC/CD3-PE/CD8-PerCPCy5.5/CD4-APC,
CD69-FITC/CD3-PE/CD8-PerCP Cy5.5/CD4-APC, all from BD Biosciences (Oxford,
UK) and CD3-PE, CD4-PE Cy5, CD8-FITC, CD19-FITC, CD56-PE Cytognos (Sala-
manca, Spain), and neutrophil granulocytes and monocytes for phagocytic function
(FTg, FTm) and oxidative burst ability (Ecg and Ecm).Blood count
Standard blood count was performed to determine the number of white cells per L of
blood in the sample. Differential count was done to acquire information on the per-
cent-distribution of specific white blood cells. Both data were used to calculate the ab-
solute number of a specific white cells population for each single individual.Flow cytometry
White blood cells were stained with specific monoclonal antibodies directed against dif-
ferent CD markers. Four colour analyses were performed concurrently to determine
the population of cells under investigation and their function. At least 1000 gated cells
were analysed for each test. Data were collected on a FACSCanto flow cytometer and
expression of various markers was assessed using FACSDiva (BD Bioscience) analysis
software.Phago-Burst Test
Phagocytosis and oxidative burst capacity was measured using Phago-burst test
(Orphegen Pharma, Heidelberg, Germany). Measurements were performed using flow
cytometer (BD, FACSCanto, USA) equipped with argon-ion laser of 488 nm excitation
wavelength.Statistical analysis
Descriptive statistics were calculated for all the measured parameters. Because of the
small sample size and the exploratory nature of the study, the change in MVIC between
the start and the end of the NMES program within each side, the difference between
sides in mean change, and the change between pre- and post-treatment data from
blood tests were tested both using paired t-test and exact Wilcoxon signed-rank
matched-pairs test (WSRMPT). For biochemical blood tests, the difference in propor-
tion of values within normal range was tested using exact McNemar's test. Because of
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so all the differences were taken as statistically significant if p< 0.05. Statistical analyses
were performed using SPSS for Windows 15.0.1.1 software (SPSS Inc.. Chicago. IL.
2007).Results
Dynamometric measurements of muscle strength
Measurements of knee extensor muscles strength before and after the NMES program
are summarised in Table 1. The increase in mean MVIC was statistically significant on
the dominant as well as on the nondominant side (p< 0.01 on both sides from t-test
and WSRMPT), though not very large (by 6 % and 5 % on average on the dominant
and the nondominant side, respectively). There was no difference between the sides in
mean MVIC increase (p= 0.979 and p= 1.000 from t-test and WSRMPT, respectively).Biochemical blood tests
The results regarding biochemical serum analyses and electrolytes are summarised in
Tables 2 and 3, respectively. Some increase after the NMES program was observed only
in creatine kinase, but it was not statistically significant. CRP values were all below the
threshold of 5 mg/L, before and after the NMES program in all the participants; there-
fore, no descriptive statistics are reported for them. Similarly, no systematic change
after the NMES program was observed in any of the electrolytes – neither in the mean
value nor or in the proportion of normal values.Immunological status
No statistically significant difference between the status before the NMES program and
the status after NMES program was found in any of the observed variables (Table 4).
The only changes close to statistical significance were the raises in percentage of CD3
cells and number and percentage of CD19 cells.Discussion
The main aim of our study was to examine the immune response after the completion
of the NMES training. The question at issue was whether the particular type of low fre-
quency therapeutic electric stimulation in healthy individuals, if frequent and long-Table 1 Descriptive statistics for maximum voluntary isometric contraction (MVIC)
measured before and after the 2-week neuromuscular electric stimulation program
(NMES), and for the difference and the ratio of the two measurements
Dominant side Nondominant side
MVIC (Nm) Before NMES After NMES Difference Ratio Before NMES After NMES Difference Ratio
Min 117 133 −2 0.99 134 142 −4 0.97
Max 328 344 30 1.21 339 353 22 1.11
Median 219.5 225.5 11.5 1.04 210.0 230.5 15.0 1.06
Mean 220.4 232.4 12.0 1.06 218.6 230.5 11.9 1.05
SD 80.0 82.2 11.2 0.07 74.7 78.71 8.5 0.04
Difference - Measurement after NMES – Measurement before NMES.
Ratio - Measurement after NMES / Measurement before NMES.
Table 2 Descriptive statistics and results of statistical tests for biochemical serum
analyses
Glucose Creatine kinase Urea Creatinine Cortisol
(mmol/L) (μkat/L) (mmol/L) (μmol/L) (mmol/L)
Before After Before After Before After Before After Before After
NMES NMES NMES NMES NMES NMES NMES NMES NMES NMES
Min 4.0 4.0 1.10 1.31 3.0 3.9 49.0 55.0 235 324
Max 5.6 5.9 7.50 12.81 6.9 7.7 107.0 103.0 889 1044
Median 5.0 4.8 2.41 4.00 5.2 5.1 72.0 75.5 450 442
Mean 4.9 4.9 3.10 4.83 5.1 5.2 76.3 78.8 479 510
SD 0.6 0.5 2.32 3.75 1.3 1.2 18.6 17.0 187 236
p (paired t) 0.788 0.146 0.654 0.185 0.576
p (EWMPT) 0.715 0.193 0.531 0.217 0.945
Normal 10 / 10 10 / 10 5 / 10 4 / 10 10 / 10 9 / 10 9 / 10 10 / 10 9 / 10 9 / 10
p (McNemar) 1.000 0.965 1.000 1.000 1.000
NMES - neuromuscular electric stimulation program.
Normal - Number of values within normal range / Number of data values.
EWMPT - exact Wilcoxon signed-rank matched-pairs test.
McNemar - exact McNemar test.
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clinically significant effect.
Some studies of this type have been carried out as in vitro experiments. A study on
immunomodulatory effects of direct and pulsed electric currents found that directly ap-
plied weak electric currents can modulate the function of different immune cells
in vitro [21,22]. In an animal experiment, it has been shown that electric stimulation
leads to acceleration of fracture healing attended by corresponding shifts of the rela-
tionship between immune processes (levels of IgM, IgG, IgA, T- and B-lymphocytes)
and activity of the regenerative processes [23].
There are also some clinical studies of the influence of low-frequency electric stimu-
lation evoking muscle contractions on neuroendocrine changes and on immune reac-
tions in humans. For example, Twist and co-workers examined the effects of
computerized functional electric stimulation (FES) exercise program on plasma β-
endorphin-like immunoreactivity (BEP-ir) and cortisol levels in spinal cord-injured
individuals, and found significantly sustained increases in BEP-ir and improved regula-
tion of cortisol together with improved depression scores after 19 and 30 weeks of
training program [24]. Furthermore, Nash reported that cycling exercise performed by
persons with quadriplegia using computer-sequenced electrically stimulated contraction
of lower leg muscles fails to provoke a leucocytosis, but transitionally elevates natural
killer (NK) cell number and citotoxicity lasting one-half hour after exercise [25]. Also,
Klokker et al. found changes in NK and other immunocompetent cells after 30 minutes
of electrically stimulated cycling exercise in spinal cord injured individuals, which
mostly returned to pre-exercise level after two hours [26]. In a study in patients with
moderate to severe heart failure, Karavidas and co-workers evaluated the impact of FES
on endothelial and peripheral markers of immune activation and observed that 6 weeks
of FES training program improved endothelial function and exhibited anti-
inflammatory effects [27]. In addition, numerous reports deal with the effect of active
exercise and physical training upon the immune system [28,29].
Table 3 Descriptive statistics and results of statistical tests for electrolytes
Glucose Creatine kinase Urea Creatinine Cortisol
(mmol/L) (μkat/L) (mmol/L) (μmol/L) (mmol/L)
Before After Before After Before After Before After Before After
NMES NMES NMES NMES NMES NMES NMES NMES NMES NMES
Min 4.0 4.0 1.10 1.31 3.0 3.9 49.0 55.0 235 324
Max 5.6 5.9 7.50 12.81 6.9 7.7 107.0 103.0 889 1044
Median 5.0 4.8 2.41 4.00 5.2 5.1 72.0 75.5 450 442
Mean 4.9 4.9 3.10 4.83 5.1 5.2 76.3 78.8 479 510
SD 0.6 0.5 2.32 3.75 1.3 1.2 18.6 17.0 187 236
p (paired t) 0.788 0.146 0.654 0.185 0.576
p (EWMPT) 0.715 0.193 0.531 0.217 0.945
Normal 10 / 10 10 / 10 5 / 10 4 / 10 10 / 10 9 / 10 9 / 10 10 / 10 9 / 10 9 / 10
p (McNemar) 1.000 0.965 1.000 1.000 1.000
NMES - neuromuscular electric stimulation program.
Normal - Number of values within normal range / Number of data values.
EWMPT - exact Wilcoxon signed-rank matched-pairs test.
McNemar - exact McNemar test.
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quently encountered, so muscle strengthening is often used. Increase in muscle
strength is usually obtained through exercise. In addition to adequately selected and
conducted active exercise, another option for muscle strengthening is neuromuscular
electric stimulation (NMES). The effects of NMES for the purpose of muscle strength-
ening have been described in healthy subjects and in several pathologies associated with
decrease of muscle strength [2,19]. The results obtained in those studies vary consider-
ably and it is difficult to compare them because of the differences in the applied
electro-stimulation procedure, as well as in the measurement of effects upon muscle
strength. Many authors describe a raise in muscle strength after NMES training, though
only a few detected statistically significant changes with respect to the baseline. The
variation among the outcomes is not surprising because the effects of NMES depend
on a number of factors, while the studies vary regarding the experimental protocol,
equipment used, characteristics of the electric pulses, duty cycles and other relevant
aspects [30].
Nevertheless, muscle strengthening using NMES has long been used in clinical prac-
tice – mainly in traumatological and orthopaedic patients without lesions of the ner-
vous system, who have weakened yet normally innervated muscles [31,32]. There are
also some lesions of the central nervous system leading to sarcopenia which could be
treated by NMES, but that needs further evaluation.
NMES is considered as a supplementary method of muscular strengthening added to
therapeutic exercise. In addition, NMES superimposed on voluntary muscle contraction
can be used in healthy persons for the preventative purposes of maintaining muscular fit-
ness. Given the lack of studies addressing eventual changes in immunological condition in
the days following the completion of a NMES program, it is therefore important that our
results indicate that therapeutic electric stimulation does not harm immune response in
healthy volunteers one day after completion of a 10-session-day NMES program.
It should be stressed that we used the standard contemporary methods for compre-
hensively assessing immune status. While even more sensitive methods might exist
Table 4 Summary of results of blood tests before and after the 2-week neuromuscular
electric stimulation program
Before NMES After NMES Before vs. After
(no. of cases)
p p
Range Mean Range Mean < = > (paired t) (EWMPT)
Leucocytes 3.8 - 8.0 5.7 4.7 - 7.9 5.7 4 1 5 0.901 0.719
Neutrophils (%) 36.4 - 67.7 51.8 37.6 - 68.9 52.4 5 0 5 0.888 1.000
Neutrophils (no.) 1.4 - 5.4 3.0 2.2 - 5.4 3.1 5 0 5 0.967 0.695
Monocytes (%) 2.8 - 7.4 4.1 3.2 - 7.8 4.2 5 1 4 0.943 0.910
Monocytes (no.) 0.1 - 0.3 0.2 0.2 - 0.5 0.2 5 0 5 0.894 0.770
Lymphocytes (%) 28.3 - 54.6 38.8 25.8 - 51.1 37.9 4 0 6 0.792 1.000
Lymphocytes (no.) 1.7 - 2.9 2.2 1.8 - 3.0 2.2 2 0 8 0.725 0.375
CD3 (%) 60.0 - 84.0 72.4 61.0 - 87.0 75.6 6 3 1 0.088 0.078
CD3 (109 cells/L) 1.012 - 2.423 1.639 1.171 - 2.460 1.686 4 0 6 0.734 0.922
CD19 (%) 2.0 - 24.0 8.5 5.0 - 23.0 10.0 7 0 3 0.051 0.059
CD19 (109 cells/L) 0.042 - 0.398 0.184 0.102 - 0.442 0.218 8 0 2 0.065 0.064
CD4 (%) 31.0 - 56.0 43.5 36.0 - 62.0 47.6 6 2 2 0.128 0.117
CD4 (109 cells/L) 0.691 - 1.483 0.997 0.766 - 1.719 1.061 5 0 5 0.473 0.770
CD8 (%) 17.0 - 45.0 27.2 15.0 - 50.0 27.1 3 2 5 0.940 0.992
CD8 (109 cells/L) 0.282 - 1.298 0.626 0.288 - 1.371 0.616 5 0 5 0.779 0.846
CD4/8 0.7 - 2.6 1.7 0.7 - 3.9 1.9 6 1 3 0.289 0.359
DR/3 (%) 4.0 - 25.0 9.0 3.0 - 20.0 8.5 4 0 6 0.485 0.561
DR/3 (109 cells/L) 0.083 - 0.558 0.207 0.061 - 0.420 0.185 4 0 6 0.302 0.432
NK (%) 6.0 - 37.0 13.7 6.0 - 26.0 13.1 4 1 5 0.829 0.633
NK (109 cells/L) 0.159 - 0.776 0.303 0.178 - 0.572 0.288 4 0 6 0.780 0.557
Th reg (%) 0.8 - 4.0 1.8 0.1 - 5.0 2.1 5 2 3 0.328 0.344
Th reg (109 cells/L) 0.014 - 0.051 0.028 0.002 - 0.077 0.036 6 0 4 0.211 0.232
CD25+CD3+ (%) 2.0 - 14.0 6.1 1.0 - 16.0 5.6 4 3 3 0.674 1.000
CD25+CD3+ (109 cells/L) 0.042 - 0.294 0.136 0.018 - 0.325 0.125 5 0 5 0.691 1.000
CD25+CD4+ (%) 3.0 - 24.0 11.5 1.0 - 24.0 11.0 5 2 3 0.805 0.938
CD25+CD4+ (109 cells/L) 0.066 - 0.312 0.183 0.025 - 0.381 0.178 6 0 4 0.964 0.846
CD25+CD8+ (%) 0.1 - 2.0 0.9 0.3 - 2.0 0.8 1 8 1 0.555 1.000
CD25+CD8+ (109 cells/L) 0.001 - 0.034 0.015 0.004 - 0.049 0.016 4 0 6 0.751 1.000
CD69+CD3+ (%) 1.0 - 8.0 2.8 1.0 - 4.0 2.2 3 5 2 0.363 0.625
CD69+CD3+ (109 cells/L) 0.021 - 0.231 0.069 0.018 - 0.088 0.049 4 0 6 0.324 0.922
CD69+CD4+ (%) 1.0 - 4.0 1.7 1.0 - 4.0 2.1 4 5 1 0.168 0.313
CD69+CD4+ (109 cells/L) 0.010 - 0.081 0.031 0.012 - 0.062 0.036 6 0 4 0.412 0.432
CD69+CD8+ (%) 1.0 - 4.0 2.4 1.0 - 4.0 2.0 3 2 5 0.309 0.344
CD69+CD8+ (109 cells/L) 0.010 - 0.097 0.042 0.016 - 0.094 0.035 4 0 6 0.308 0.375
FTg (%) 84.3 - 97.1 90.5 84.1 - 97.0 91.5 5 0 5 0.334 0.322
FTm (%) 68.7 - 92.1 82.0 80.6 - 93.4 84.3 6 0 4 0.538 0.492
Ecg (%) 89.8 - 98.7 93.6 84.0 - 98.9 91.8 5 0 5 0.422 0.375
Ecm (%) 77.7 - 95.8 86.0 71.4 - 95.8 87.0 7 0 3 0.632 0.322
EWMPT - exact Wilcoxon signed-rank matched-pairs test.
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tainty that the treatment did not produce any physiologically or clinically significant
change in the functioning of the immune system.
From the methodological point of view, the issue of sample size (and study power)
should be addressed. Namely, one may be tempted to conclude that the absence of any
statistically significant effect was due to the small sample size, but because no correc-
tion for multiple testing was applied the p-values underestimate the true probability of
falsely rejecting the null hypothesis. It becomes clear that such "compensation" is suffi-
cient if one considers that had the Bonferroni adjustment been applied (which is, of
course, overly conservative, especially with correlated outcomes like in our study, but
suffices for illustrative purposes), all p-values in Table 4 would equal 1. It should also
be stressed that no formal sample size calculation could have been performed because
of the lack of directly comparable previous research, while calculating "post-hoc"
("observed", "retrospective", "achieved") statistical power would not be the right way to
address the "sensitivity" of our study [33,34]. In addition to statistical arguments, clin-
ical significance should also be considered. As far as the biochemical serum analyses
and electrolytes are concerned, the fact that the proportion of values within the normal
range remained practically identical after the NMES program leaves little doubt. Simi-
larly, the three possibly increased immunological status parameters were within the
reference range (with negligible exceptions) before and after the program in all the par-
ticipants, the reference range being 54.9-84.0 % for the percentage of CD3 cells, 4.7-
19.1 % for the percentage of CD19 cells, and 0.072-0.460 × 109 cells/L for the number
of CD19 cells [35].
Nevertheless, while drawing the conclusion that neuromuscular electric stimulation
does not affect immunological status, one should bear in mind that the performed elec-
tric stimulation was relatively moderate in terms of intensity of the electric pulses. It is
therefore not known what the immune response would be using higher amplitude and/
or different frequencies of electric stimulation, treatment of different duration and/or
of different tissues.Conclusions
Measurements of maximum torque of isometric contraction during maximum volun-
tary isometric contraction showed that muscle strength slightly increased after ten ses-
sions of a neuromuscular electric stimulation training program. At the same time, we
found no statistically or clinically significant change of the biochemical blood para-
meters or of the immunological status parameters monitored in our study group of
healthy persons one day after the treatment with neuromuscular electric stimulation.Competing interests
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